BONS on Tel Aviv Stock Exchange
Bonus Biogroup Ltd.
Bonus Biogroup Ltd. is an Israeli biological products company, founded in 2012.1 Its website says: “We develop investigational cell therapies that are designed to leverage the natural properties of mesenchymal cells and provide multi-functional therapeutic mechanisms to modulate inflammation and promote tissue repair. These therapies are currently being evaluated in clinical trials.”4 Its shares trade on Tel Aviv Stock Exchange under the symbol BONS.1
Price unavailable
Last updated Oct 21, 2026.
Overview
Timeline
- 2012Founded Founded in Israel1
Filings
8 filings to the SEC since October 2021: 8 other. The latest 8:
- Mar 31, 2026F-1/A AMENDMENT NO. 4 TO FORM F-1 EDGAR
- Mar 19, 2026F-1/A AMENDMENT NO. 3 TO FORM F-1 EDGAR
- Mar 12, 2026FWP FREE WRITING PROSPECTUS EDGAR
- Mar 12, 2026F-1/A AMENDMENT NO. 2 TO FORM F-1 EDGAR
- Nov 28, 2025F-1/A AMENDMENT NO. 1 TO FORM F-1 EDGAR
- May 9, 2025F-1 REGISTRATION STATEMENT EDGAR
- Apr 10, 2025DRS/A EDGAR
- Feb 27, 2025DRS EDGAR
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
SEC filer profile
How Bonus Biogroup Ltd. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARBonus Biogroup Ltd.2
- CIK0001710531
- Incorporated inIsrael2
- Fiscal year endsDecember 312
- Industry code (SIC)2836 Biological Products, (No Diagnostic Substances)2
- SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance2
- Business addressP.O. Box 15143, Haifa, Israel2
- Phone9727320671002
- On EDGAR sinceFeb 27, 20252
- Filings8 in all: F-1/A (4), DRS (1), DRS/A (1), F-1 (1), FWP (1)2
Links
- Websitewww.bonusbiogroup.com1
- WikidataQ110460019
- SEC EDGARCIK 1710531
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1WikidataBonus Biogroup Ltd. on Wikidata
- 2
- 3
- 4Company websiteBonus Biogroup Ltd. website